维普期刊资源整合服务平台（V6.5）

147篇 您的检索式：作者名="Lipsic"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study显示文摘	Dirk J. A. Lok Peter Meer Pieta W. Bruggink-André Porte Erik Lipsic Jan Wijngaarden Hans L. Hillege Dirk J. Veldhuisen	2010	Clinical Research in Cardiology2010，，5：	2
2	A functional erythropoietin receptor in a rat heart is linked to anti-apoptotic effects 显示文摘	van der Meer P Lipsic E Boer RA	2003	J Am Coil Cardiol2003，41，：	1
3	Erythropoietin induces revascularization and improves cardiac function in rats heart failure after myocardial infarction显示文摘	Vander Meer P Lipsic E Henning RH	2005	J Am Coll Cardiol2005，46，1：	1
4	Erythropoietin in cardiovascular diseases显示文摘	Vander Meer P Voors AA Lipsic E	2004	Eur Heart J2004，25，17：	1
5	Timing of erythropoietin treatment for cardioprotection in ischemia/ reperfusion显示文摘	Lipsic E van der Meer P Henning RH	2004	J Cardiovasc Pharmacol2004，44，4：	1
6	Protective effects of erythropoietin in cardiac ischemia: from bench to bedside 显示文摘	Lipsic E Schoemaker RG van der Meer P	2006	Am Coll Cardiol2006，48，11：	1
7	Timing of erythropoietin treatment for cardio protection in ischemial reperfusion显示文摘	LIPSIC E VAN DER MEER P HENNING R H	2004	J Cardiovasc Pharmacol2004，44，：	1
8	Erythropoietin in car- diovascular diseases 显示文摘	Van der Meer P voors AA Lipsic E	2004	Eur Heart J2004，25，4：	1
9	Ti ming of erythropoietin treatment for cardioprotection in ischemia/reperfusion显示文摘	Lipsic E Van der Meer P Henning RH	2004	J Cardiovasc Pharmaclo2004，44，4：	1
10	Timming of erythropoietin treatment of cardioprotection in ischemia/reperfusion显示文摘	Lipsic E van der Meer P Henning RH	2004	J Cardiovasc Pharmacol2004，44，4：	1
11	Prognostic value of plasma eryth- ropoietin on mortality in patients with chronic heart failure显示文摘	van der Meer P Voors AA Lipsic E	2004	J Am Coll Car- diol2004，44，1：	1
12	Timing of erythropoietintreatment for cardioprotection in isehemia/reperfusion 显示文摘	Lipsic E van der Meer P Henning RH	2004	J CardiovascPharmaco12004，44，4：	1
13	Protective effects of erythropoietin in cardiac ischemia显示文摘	Lipsic E Schoemaker RG van der Meer P	2006	J Am Coll Cardiol2006，48，：	1
14	Erythropoietin in cardiovascular diseases显示文摘	van der Meet P Voors AA Lipsic E	2004	Eur Heart J2004，25，4：	1
15	Protective effects of erythropoietin in cardiac ischemia: from bench to bedside显示文摘	LIPSIC E SCHOEMAKER RG VAN DER MEER P	2006	J Am Coil Cardio2006，48，11：	1
16	Erythropoietin in cardiovascular disease显示文摘	Voors AA Lipsic E	2004	Eur Heart J2004，25，：	1
17	Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit 显示文摘	Lipsic E Westenbrink B D van der Meer P	2008	Eur J Heart Fail2008，10，1：	1
18	Timing of erythropoietin treatment for cardioprotection in sichemia/ reperfusion显示文摘	Van der Meer P Henning RH	2004	J Cardiovasc Pharmacol2004，44，4：	1
19	Erythropoietin in cardiovascular diseases显示文摘	Van der Meer P Voors AA Lipsic E	2004	Eur Heart J2004，25，4：	1
20	Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction ( GIPS)-Ⅲ trial 显示文摘	Lexis CP van der Horst IC Lipsic E	2012	Cardiovasc Drugs Ther2012，26，5：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示